About Enhabit, Inc. 
Enhabit, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 42 Schemes (37.36%)
Foreign Institutions
Held by 75 Foreign Institutions (22.07%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
266 Million
(Quarterly Results - Jun 2025)
Net Profit:
6 Million
Pharmaceuticals & Biotechnology
USD 544 Million (Micro Cap)
22.00
NA
0.00%
0.73
7.71%
0.96






